Jazz Pharmaceuticals (JAZZ) Curent Deferred Tax Liability (2012 - 2015)

Jazz Pharmaceuticals' Curent Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $9.4 million for Q3 2015.

• In Q3 2015, Curent Deferred Tax Liability rose 50.46% year-over-year to $9.4 million; the TTM figure through Sep 2015 stood at $9.4 million (up 50.46% YoY), while the FY2014 annual figure was $9.4 million, up 50.66% from the prior year.
• Curent Deferred Tax Liability for Q3 2015 stood at $9.4 million, roughly flat from $9.4 million in the prior quarter.
• The five-year high for Curent Deferred Tax Liability was $9.4 million in Q2 2015, with the low at $259000.0 in Q1 2013.
• The 4-year median for Curent Deferred Tax Liability is $6.3 million (2013), against an average of $5.3 million.
• The sharpest annual moves came in 2014 and 2015: Curent Deferred Tax Liability soared 2316.6% in 2014, then soared 50.46% in 2015.
• Jazz Pharmaceuticals' Curent Deferred Tax Liability stood at $275000.0 in 2012, then surged by 2176.0% to $6.3 million in 2013, then surged by 50.66% to $9.4 million in 2014, then dropped by 0.14% to $9.4 million in 2015.
• Business Quant data shows JAZZ's Curent Deferred Tax Liability at $9.4 million in Q3 2015, $9.4 million in Q2 2015, and $9.4 million in Q1 2015.